J. Quint

First name
Middle name
Last name
Wilkinson, A. J. K., Maslova, E., Janson, C., Radhakrishnan, V., Quint, J. K., Budgen, N., et al. (2024). Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study. Thorax. http://doi.org/10.1136/thorax-2023-220259
Whittaker, H., Rothnie, K. J., & Quint, J. K. (2023). Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records. Plos One, 18, e0292876. http://doi.org/10.1371/journal.pone.0292876
Graul, E. L., Nordon, C., Rhodes, K., Marshall, J., Menon, S., Kallis, C., et al. (2023). Temporal Risk of Non-Fatal Cardiovascular Events Post COPD Exacerbation: A Population-based Study. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.202307-1122OC
Amegadzie, J. E., Gao, Z., Quint, J. K., Russell, R., Hurst, J. R., . Y. Lee, T., et al. (2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. http://doi.org/10.1136/thorax-2023-220615
Rothnie, K. J., Numbere, B., Gelwicks, S., Lu, Y., Sharma, R., Compton, C., et al. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. Int J Chron Obstruct Pulmon Dis, 18, 2673-2685. http://doi.org/10.2147/copd.s413947
Kallis, C., Morgan, A., Fleming, L., & Quint, J. K. (2023). Prevalence of Poorly Controlled Asthma and Factors Associated with Specialist Referral in Those with Poorly Controlled Asthma in a Paediatric Asthma Population. J Asthma Allergy, 16, 1065-1075. http://doi.org/10.2147/jaa.s428623
Kallis, C., Calvo, R. A., Schuller, B., & Quint, J. K. (2023). Development of an Asthma Exacerbation Risk Prediction Model for Conversational Use by Adults in England. Pragmat Obs Res, 14, 111-125. http://doi.org/10.2147/por.s424098
Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C., et al. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039-2054. http://doi.org/10.2147/copd.s408688
Zhang, X., & Quint, J. K. (2023). Online Survey to Investigate Asthma Medication Prescription and Adherence from the Perspective of Patients and Healthcare Practitioners in England. J Asthma Allergy, 16, 987-996. http://doi.org/10.2147/jaa.s426227
Graul, E. L., Stone, P. W., Massen, G. M., Hatam, S., Adamson, A., Denaxas, S., et al. (2023). Determining prescriptions in electronic healthcare record data: methods for development of standardized, reproducible drug codelists. Jamia Open, 6, ooad078. http://doi.org/10.1093/jamiaopen/ooad078